Please provide your email address to receive an email when new articles are posted on . Lung transplant-listed patients with BPD were younger and more were on mechanical ventilation vs. those with ...

DENVER, April 22, 2022 – A randomized controlled trial evaluates if selective early treatment of patent ductus arteriosus reduces death or bronchopulmonary dysplasia at 36 weeks in extreme preterm ...

Bronchopulmonary dysplasia (BPD) is an important cause of respiratory illness in preterm infants that results in significant ...

Hydrocortisone is no more effective than placebo at preventing damage that can result from oxygen and ventilator therapy necessary to keep preterm infants alive, according to research funded by the ...

Please provide your email address to receive an email when new articles are posted on . Caring for premature babies with bronchopulmonary dysplasia, which is a serious lung condition that occurs in ...

Bronchopulmonary dysplasia (BPD) is a chronic disease of the lungs that mainly affects premature newborns, especially those who receive mechanical ventilation, which can contribute to altering normal ...

Bronchopulmonary dysplasia (BPD), a chronic lung disease affecting premature infants, was first described in 1967 by Northway and two other researchers. Over the years, the characteristic features of ...

Researchers found that in preterm infants at high risk for bronchopulmonary dysplasia, adverse events occurred in nearly all infants regardless of treatment group. Furosemide increased the risk of ...

High-dose enteral vitamin A supplementation in the early postnatal period was safe but failed to reduce the likelihood of moderate or severe bronchopulmonary dysplasia in extremely low birthweight ...

Azithromycin for premature newborns requiring breathing support failed to improve rates of survival without moderate or severe bronchopulmonary dysplasia at 36 weeks' postmenstrual age, though it ...